These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24569065)

  • 21. Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.
    Matthai WH
    Curr Hematol Rep; 2006 Mar; 5(1):95-9. PubMed ID: 16537053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban.
    Harenberg J; Jörg I; Fenyvesi T; Piazolo L
    J Thromb Thrombolysis; 2005 Feb; 19(1):65-9. PubMed ID: 15976970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful Anticoagulation Using Argatroban During Transcatheter Aortic Valve Implantation in a Patient With Heparin-Induced Thrombocytopenia.
    Naganuma T; Mitomo S; Kin N; Nakamura S
    A A Case Rep; 2016 Oct; 7(7):158-60. PubMed ID: 27513970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin-induced thrombocytopenia II-induced critical limb ischaemia treated with urokinase and argatroban.
    Beyer J; Halbritter K; Weise M; Leonhard J; Schellong S
    Thromb Haemost; 2007 Aug; 98(2):470-2. PubMed ID: 17721634
    [No Abstract]   [Full Text] [Related]  

  • 26. [Argatroban, a new antithrombotic treatment for heparin-induced thrombocytopenia application in cardiac surgery and in intensive care].
    Rozec B; Boissier E; Godier A; Cinotti R; Stephan F; Blanloeil Y
    Ann Fr Anesth Reanim; 2014; 33(9-10):514-23. PubMed ID: 25148720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.
    Rice L; Hursting MJ; Baillie GM; McCollum DA
    J Clin Pharmacol; 2007 Aug; 47(8):1028-34. PubMed ID: 17525167
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombotic end point for assessing argatroban therapy for heparin-induced thrombocytopenia: learning from secondary analyses of prospective studies.
    Warkentin TW
    Chest; 2006 Jun; 129(6):1396-8. PubMed ID: 16778250
    [No Abstract]   [Full Text] [Related]  

  • 29. Evolving management strategies for heparin-induced thrombocytopenia.
    Rice L
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S15-21. PubMed ID: 16105554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report.
    Lewis BE; Rangel Y; Fareed J
    Angiology; 1998 Jan; 49(1):61-7. PubMed ID: 9456166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of heparin-induced thrombocytopenia by use of argatroban, a synthetic thrombin inhibitor.
    Matsuo T; Kario K; Chikahira Y; Nakao K; Yamada T
    Br J Haematol; 1992 Nov; 82(3):627-9. PubMed ID: 1486048
    [No Abstract]   [Full Text] [Related]  

  • 32. Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor.
    LaMonte MP; Brown PM; Hursting MJ
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):31-41. PubMed ID: 15723573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombelastography in a patient with heparin-induced thrombocytopenia treated with argatroban.
    Zayac EA; Pivalizza EG; Levine RL
    Anesth Analg; 2008 Jan; 106(1):351-2. PubMed ID: 18165611
    [No Abstract]   [Full Text] [Related]  

  • 34. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
    Lewis BE; Walenga JM; Wallis DE
    Semin Thromb Hemost; 1997; 23(2):197-202. PubMed ID: 9200347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The paradox of heparin-induced thrombocytopenia: the initial management.
    Taylor LM; Smith KM
    Orthopedics; 2005 Jun; 28(6):559-62. PubMed ID: 16138467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of heparin-induced thrombocytopenia.
    Donovan JL; Tran MT; Kanaan AO
    J Pharm Pract; 2010 Jun; 23(3):226-34. PubMed ID: 21507818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hitting back HIT.
    Gude D
    Ann Card Anaesth; 2012; 15(2):168-9. PubMed ID: 22508216
    [No Abstract]   [Full Text] [Related]  

  • 38. Heparin-induced thrombocytopenia in haemodialysis treated with argatroban.
    Quiñones-Ortiz L; Suárez-Laurés A; Pablos-de Pablo M; Robles V; Calzón-Blanco C; Quiñones-Pérez S; Ayausty-Ruiz A
    Nefrologia; 2014; 34(5):670-4. PubMed ID: 25036261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intraoperative management for a patient with heparin-induced thrombocytopenia (HIT) undergoing off-pump coronary bypass surgery using argatroban, a direct thrombin inhibitor].
    Ohno H; Yokoi M
    Masui; 2002 Jan; 51(1):30-3. PubMed ID: 11840659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Argatroban: pharmacological properties and anaesthesiological aspects].
    Kleinschmidt S; Stephan B; Pindur G; Bauer C
    Anaesthesist; 2006 Apr; 55(4):443-50. PubMed ID: 16389543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.